Back to Search
PAUL THAMBI, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1952482655IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
D0061083(MD)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 1996
Research & Publications (3)
A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days.
PMID 15800893·Cancer·2005
3-trial
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma.
PMID 15269145·Clin Cancer Res·2004
3-trial
STI571 (imatinib mesylate): the tale of a targeted therapy.
PMID 11901302·Anticancer Drugs·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2950 CLEVELAND CLINIC BLVD
WESTON, FL 33331 - Phone
- (877) 463-2010
Quick Facts
- NPI
- 1952482655
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 3
Are you this provider?
Claim Your Profile